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Previewsstimulated in vitro. The model used by Cui
et al. deliberately limited deletion of
STAT3 to activated T cells; hence they
were not in a position to address a role
for the factor in the naive pool—but this
is fertile ground for new studies in mice.
Together, these complementary stud-
ies in mice and humans establish an
important role for STAT3 in memory
T cell formation and suggest that cyto-
kines such as IL-10 and IL-21 may be crit-
ical in dictating whether activated T cells
will divert to the effector population or
join the ranks of the functional memory
T cell pool.REFERENCES
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In this issue of Immunity, Choi et al. (2011) analyzed the cellular composition of aortic vessels in normal
and atherosclerotic mice, revealing the presence of conventional CD103+ DCs with a potentially protective
influence on atherosclerosis.Atherosclerosis with its typical complica-
tions of stroke and heart attack continues
to be the primary cause of death in
westernized societies. In this issue of
Immunity, Steinman and colleagues ex-
plore the cellular composition of normal
and atherosclerotic aortic tissue, confirm-
ing the presence of macrophages and
dendritic cells (DCs) of monocyte origin
but also revealing the presence of a
CD103+ DC subset that is developmen-
tally dependent on FMS-like tyrosine
kinase 3 receptor ligand (Flt3L) and is of
nonmonocyte origin (Figure 1). Associa-
tion of this DC population with athero-
sclerotic tissues appears to be protective
and correlates with a relative increase in
regulatory T (Treg) cells.
A simplified view of atherosclerosis en-
visages a sequential model (Libby et al.,
2011), whereby hemodynamic forces im-
pacting on distinct areas of the vascula-
ture, such as the lesser curvature of theaortic arch, result in qualitative changes
to endothelial cells lining these vessels.
Changes include upregulation of adhe-
sion molecules through which circulating
monocytes gain access to the intima, an
area of connective tissue located immedi-
ately below the basement membrane of
the endothelium (Figure 1). Endothelial
dysfunction also affects vessel wall per-
meability, promoting uptake and reten-
tion of circulating lipids, such as choles-
terol-containing low-density lipoproteins
(LDLs). These fatty particles are engulfed
by monocyte-derived macrophages that
eventually become engorged to his-
tologically appear as ‘‘foam cells’’ (Lusis,
2000). The crystalline nature of some of
these deposits not only makes their elim-
ination by macrophages difficult, but also
evokes inflammasome activation and the
secretion of proinflammatory cytokines.
The consequence of this inflammatory
response is swelling of the intimal space,perpetuation of endothelial dysfunction,
further recruitment of leukocytes, and
exacerbation of hemodynamic stress
due to bulging of the lesion into the vessel
lumen. When the endothelial lining even-
tually ruptures, platelet activation and
thrombus formation lead to the charac-
teristic atherosclerotic lesions that can
either occlude the vessel lumen locally
or, upon dislodgement, block distant
arteries.
Atherosclerosis is not only a critical
medical concern, but represents an in-
teresting disease for immunologists to
study basic mechanisms of localized in-
flammation. Although atherosclerosis is
associated with intimal immigration of
a variety of leukocytes, including mono-
cytes, DCs, T cells, B cells, and mast
cells, it is widely believed that monocyte-
derived macrophages are the dom-
inant phagocytic cell type involved in the
pathogenesis of this disease. Buildingovember 23, 2011 ª2011 Elsevier Inc. 665
Figure 1. Diagram of Aortic Regions with a Schematic Cross-section of the Vessel Wall
Showing Developing Atherosclerosis
The intima is infiltrated by monocyte-derived macrophages (CD11clo CD11b+ F4/80+ MHClo),
some of which develop into foam cells upon accumulation of modified low density lipoproteins. The
intima also contains monocyte-derived dendritic cells (CD11chi MHChi CD11b+ F4/80+) and a population
of Flt3-dependent dendritic cells (CD11chi MHChi CD11b CD103+) that are not of monocyte origin. This
latter population appears to be atheroprotective, possibly through their ability to interact with Treg cells.
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Previewson earlier work (Choi et al., 2009; Weber
et al., 2008), Steinman and colleagues
observed that aortic tissues contained a
substantial proportion of cells with a DC
phenotype (CD11chi MHC IIhi) (Figure 1).
To ensure that these cells were indeed
DCs, they performed a series of experi-
ments. Combining flow cytometry and666 Immunity 35, November 23, 2011 ª2011immunofluorescence, they observed that
CD11chi MHC IIhi cells increased in
mice treated with the DC growth factor
Flt3L, whereas the number of CD11clo
F4/80+ cells remained unchanged. The
latter cells were then revealed to be
macrophages, given that they displayed
excellent phagocytic activities, althoughElsevier Inc.their ability to stimulate naive CD4+ and
CD8+ T cells was poor. Conversely,
CD11chi MHC IIhi cells took up beads
poorly, but were efficient stimulators
of T cells. Together with the selective
absence of CD11clo F4/80+ cells in mice
lacking macrophage colony stimulating
factor, these findings show that the
mouse aortic tissues examined here
contained populations of macrophages
(CD11clo F4/80+) and DCs (CD11chi
MHC IIhi). Thus, whereas previous studies
had reported the presence of cells with
DC-like characteristics in vessel tissues,
the present study defines what consti-
tutes a macrophage and a DC in vessel
tissues by using developmental and func-
tional distinctions.
It had been assumed that DCs found
in aortic tissues were only of the inflam-
matory type that differentiates in situ
from monocytes (Weber et al., 2008).
The author’s first clue that this might not
necessarily be the case came from immu-
nohistology showing that not all CD11chi
MHC IIhi cells coexpressed CD11b. Flow
cytometry subsequently revealed that
the aortic tissues contained two distinct
types of DCs: one characterized by
expression of high amounts of CD11b
and F4/80 (CD11b+ DC) and another
expressing low amounts of CD11b,
but staining positive for the integrin
CD103 (CD103+ DCs). This observation
aligns very well with the DC subset com-
position of other peripheral organs, such
as the skin or lungs, in which a distinct
CD11b+ DC subset can be separated
from CD103+ DCs (Heath and Carbone,
2009). Consistent with their disparate
developmental origins, Steinman and
colleagues found that CD103+ DCs were
selectively increased in the presence of
Flt3L and absent from aortic tissues of
Flt3/ mice. In contrast, CD11b+ DCs
were implicated to arise from monocytes
through a series of experiments involving
CD11b-DTR mice, Csf1/ mice, and
in vivo labeling studies with an antibody
against DC-SIGN. Thus, a key finding
from this work is that the aortic intima
contains conventional DCs that differen-
tiate from Flt3-dependent precursors,
rather than monocytes, in addition to the
previously described monocyte-derived
DCs.
Importantly, Choi et al. (2011) find that
the presence of Flt3-dependent CD103+
DCs is inversely correlated with aortic
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Previewslesions size, suggesting an atheroprotec-
tive role for this DC subset. On the basis of
a relative increase in regulatory T cells
within lesions, reduced tissue expression
of mRNA for proinflammatory cytokines,
and previous reports of atheroprotective
effects of Treg cells (Ait-Oufella et al.,
2006), the authors suggest that the
protective role of CD103+ DC relates to
their ability to regulate local Treg cell
homeostasis. Although such a conclusion
is consistent with reports of Treg cell
stimulation by CD103+ DCs in the intes-
tine (Coombes et al., 2007), these latter
DCs express CD11b (Edelson et al.,
2010) and are probably distinct from
those in the aortic tissue. An important
control experiment for these findings in
Flt3/mice was that plasma lipid profiles
were not different relative to control mice,
as at least some of the DCs that are
missing in these mice could act as sinks
for oxidized LDLs through their selective
expression of the translocase CD36.
One of the intriguing aspects of this
study relates to the distribution of the
different DC subsets throughout different
anatomical parts of the ‘‘normal’’ aorta.
The aortic sinus, which describes a wid-
ening of the aortic diameter at its origin
at the heart, had more CD103+ DCs rela-
tive to CD11b+ DCs when compared to
other areas such as the thoracic aorta. In
this respect, it is also interesting to note
that the increase in Flt3-sensitive DCs
(CD103+ DCs) was very prominent at
the opening of an arterial branch. This
uneven distribution pattern between the
two DC subsets in aortic tissues corre-
lates nicely with the typical distribution
pattern of atherosclerotic lesions, which
develop predominantly at sites subjectedto strong hemodynamic forces, such as
the aortic sinus, the lesser curvature of
the aorta or branch points of smaller
vessels. Although lesion development
is much more accentuated in mouse
models of atherosclerosis, atheroscle-
rotic lesions also develop in normal mice
and healthy humans. Immediate precur-
sors to atherosclerotic lesions (‘‘fatty
streaks’’) can be found in the aorta of
healthy humans as early as in the first
decade of life (Libby et al., 2011). It is
therefore possible that the ‘‘normal’’ B6
mice utilized to analyze the distribution
pattern of the DCs already had athero-
sclerotic lesions in these predilection
spots and that the relative dominance of
CD103+ DCs over CD11b+ DCs in these
areas was a consequence of developing
disease. The demonstration of elevated
numbers of Flt3-dependent CD103+ DCs
in atherosclerotic lesions of Ldlr/ mice
fed a high-fat diet further supports this
view. It will be important to examine the
causal relationship between this increase
and the development of atherosclerotic
lesions. Because CD103+ DCs usually
reside in the tissues and upon maturation
migrate via afferent lymphatics into the
local draining lymph node (Heath and
Carbone, 2009), it will also be interesting
to examine whether CD103+ DCs migrate
from the intima to draining LN.
Whereas this study by Steinman and
colleagues implicates CD103+ DCs in
an atheroprotective role, it did not specif-
ically address how monocyte-derived
DCs contributed to atherosclerosis de-
velopment. However, a very recent
study shows that a type of CD11b+ DC
characterized by the production of
CCL17 appears to promote atheroscle-Immunity 35, Nrosis development and to inhibit Treg
cell responses (Weber et al., 2011), raising
the possibility that local Treg cell
responses during atherosclerosis are
regulated through a balance between
inhibitory effects by monocyte-derived
DCs and activating signals exerted by
CD103+ DCs. Clearly more work is re-
quired to delineate precisely how these
distinct types of DC impact on athero-
sclerosis development.
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